News

From the College of Natural Sciences
Scientists Develop Mosquito-Killing Algae

Scientists Develop Mosquito-Killing Algae

David Herrin, University of Texas at Austin professor of molecular biosciences, led a team of researchers which has developed algae that produce chemicals toxic to disease-carrying mosquitoes. 

Drug Engineered at UT Austin to Treat Anthrax Gains FDA Approval

Drug Engineered at UT Austin to Treat Anthrax Gains FDA Approval

Researchers at The University of Texas at Austin successfully culminated years of work when a drug they engineered for the treatment and prevention of inhalational anthrax — the anthrax antitoxin obiltoxaximab — received approval March 21 from the U.S. Food and Drug Administration (FDA).

Podcast: Jekyll and Hyde Bacteria

Podcast: Jekyll and Hyde Bacteria

To study diseases, biologists often make models, for example, a rat with a disorder similar to Alzheimer's. With a good model, they can tinker with different variables and see if anything halts the disease, without the ethical limits of experimenting on actual humans. But scientists studying an especially nasty bacterium that tends to invade and breed out of control in the lungs of people with cystic fibrosis (CF) kept hitting dead ends in their search for a good model.

Researchers Try To Develop Zika Detection, Understand Epidemiology

Researchers Try To Develop Zika Detection, Understand Epidemiology

​Undergraduate researchers in UT Austin's Freshman Research Initiative (FRI) join the effort to develop a readily available test for the newly spreading Zika virus. 

Common Colds at School a Primary Driver of Asthma Hospitalizations for Children

Common Colds at School a Primary Driver of Asthma Hospitalizations for Children

The most dangerous times of year for children with asthma are soon after their schools reopen after a break, and a new study finds that cold viruses are largely to blame.

Center for Infectious Disease Named for Dr. John Ring LaMontagne

Center for Infectious Disease Named for Dr. John Ring LaMontagne

A research center at The University of Texas at Austin will be renamed for Dr. John Ring LaMontagne, a scientist who combated flu and other infectious diseases to improve public health around the globe. The renaming of the existing Center for Infectious Disease follows more than $7 million in contributions by the LaMontagne community of family, friends and colleagues in celebration of Dr. Montagne's work within the National Institutes of Health (NIH).

Promising New Target in War Against Flu

Promising New Target in War Against Flu

Scientists at The University of Texas at Austin have discovered that a protein produced by the influenza A virus, which causes flu, can overcome one of our body's natural defense mechanisms. That makes this flu protein a potentially good target for antiviral drugs directed against the flu virus

Image credit: Pixabay, via Creative Commons CC0 license.
Bacteria Suppress Their Antibiotic-Resistant Cousins

Bacteria Suppress Their Antibiotic-Resistant Cousins

Researchers studying a dangerous type of bacteria have discovered that the bacteria have the ability to block both their own growth and the growth of their antibiotic-resistant mutants. The discovery might lead to better ways to fight a class of bacteria that have contributed to a growing public health crisis by becoming increasingly resistant to antibiotic treatments.

Two Elected to the American Academy of Arts and Sciences

Two Elected to the American Academy of Arts and Sciences

The American Academy of Arts and Sciences announced this week the election of two new members from The University of Texas at Austin—mathematician Björn Engquist and biochemist George Georgiou.

UT Austin Researchers Evaluate Methodology of Ebola Vaccine Trials

UT Austin Researchers Evaluate Methodology of Ebola Vaccine Trials

Medical aid workers in full protective gearThe waning number of Ebola cases is good news for West Africa, but for those developing a vaccine for the disease, it means time is running short.